2-(2,3-dicarboxycyclopropyl)glycine has been researched along with reserpine in 1 studies
| Studies (2-(2,3-dicarboxycyclopropyl)glycine) | Trials (2-(2,3-dicarboxycyclopropyl)glycine) | Recent Studies (post-2010) (2-(2,3-dicarboxycyclopropyl)glycine) | Studies (reserpine) | Trials (reserpine) | Recent Studies (post-2010) (reserpine) |
|---|---|---|---|---|---|
| 166 | 0 | 27 | 15,546 | 223 | 436 |
| Protein | Taxonomy | 2-(2,3-dicarboxycyclopropyl)glycine (IC50) | reserpine (IC50) |
|---|---|---|---|
| Bile salt export pump | Homo sapiens (human) | 8.7875 | |
| ATP-dependent translocase ABCB1 | Homo sapiens (human) | 3.2092 | |
| Quinolone resistance protein NorA | Staphylococcus aureus | 8.5429 | |
| Mu-type opioid receptor | Homo sapiens (human) | 4.152 | |
| Chromaffin granule amine transporter | Homo sapiens (human) | 0.05 | |
| Synaptic vesicular amine transporter | Rattus norvegicus (Norway rat) | 0.0034 | |
| Synaptic vesicular amine transporter | Homo sapiens (human) | 0.0147 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chadha, A; Dawson, L; Duty, S; Megalou, M | 1 |
1 other study(ies) available for 2-(2,3-dicarboxycyclopropyl)glycine and reserpine
| Article | Year |
|---|---|
The group II metabotropic glutamate receptor agonist, DCG-IV, alleviates akinesia following intranigral or intraventricular administration in the reserpine-treated rat.
Topics: Animals; Anticonvulsants; Antipsychotic Agents; Cyclopropanes; Dyskinesia, Drug-Induced; Glycine; Injections; Injections, Intraventricular; Male; Motor Activity; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Reserpine; Substantia Nigra | 2000 |